Gamma knife surgery for epilepsy related to hypothalamic hamartomas

Area of Science:

• Pediatric Neurosurgery
• Epilepsy Management
• Radiation Oncology

Background:

• Children with hypothalamic hamartomas (HHs) often present with severe epilepsy, posing treatment challenges.
• Traditional resective surgery carries risks of cognitive impairment, particularly short-term memory deficits.
• Less invasive treatment options are sought to mitigate surgical risks while effectively managing epilepsy.

Purpose of the Study:

• To evaluate the efficacy and safety of Gamma Knife radiosurgery (GKS) as a treatment for pediatric hypothalamic hamartomas (HHs).
• To compare GKS outcomes with traditional neurosurgical approaches, focusing on seizure control and neurocognitive function.
• To establish a treatment strategy based on HH topological classification for optimal patient selection.

Main Methods:

• Retrospective analysis of pediatric patients with hypothalamic hamartomas (HHs) treated with Gamma Knife radiosurgery (GKS).
• Classification of HHs based on a topological system to guide treatment decisions.
• Assessment of seizure frequency, neurological complications, and cognitive/behavioral outcomes post-GKS.

Main Results:

• Three years after GKS, 60% of patients achieved excellent seizure control (40% complete cessation, 20% rare seizures).
• Significant improvements in behavior and cognition were observed in many patients following GKS.
• No permanent neurological complications were reported; rare transient poikilothermia was the only noted adverse event.

Conclusions:

• Gamma Knife radiosurgery (GKS) is a safe and effective treatment for specific types of hypothalamic hamartomas (HHs), particularly Type I and small Type III.
• GKS provides comparable seizure control to microsurgery with a significantly lower risk profile, though with a delayed effect.
• Early intervention with a curative approach, guided by HH topology, is crucial for young patients with severe epilepsy and neurocognitive comorbidities.